Targeting of EGFR and HER2 with therapeutic antibodies and siRNA

Conclusion The epidermal growth factor receptor HER2 is a promising anti-tumor target for the therapy of glioblastoma. HER2 targeting may represent a promising strategy to induce cell physiological and radiobiological anti-tumor effects in glioblastoma.

http://link.springer.com/10.1007/s00066-014-0743-9

Source: Strahlentherapie und Onkologie - January 29, 2015 Category: Cancer & Oncology Source Type: research